Alan A. Rosen, MD, PA

Baltimore, Maryland 21215

0 studies enrolling now · 2 studies all time

What they study most

Gastroesophageal Reflux Disease (GERD), Irritable Bowel Syndrome Characterized by Constipation

Studies at this site

• A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs) — Stopped early
• A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) — Completed